Table 2

Bivariate associations of patient factors with completion of guideline-recommended postpartum screening among women with gestational diabetes mellitus (GDM): the Gestational Diabetes’ Effects on Moms (GEM) study (N=1642)

Screened
(n=857)
Unscreened
(n=785)
P value
Racial/ethnic background<0.0001
Black21 (2.5)40 (5.1)
Chinese American128 (14.9)47 (6.0)
Filipina100 (11.7)81 (10.3)
South Asian86 (10.0)65 (8.3)
Asian, other95 (11.1)69 (8.8)
Latina161 (18.8)180 (22.9)
Non-Hispanic White198 (23.1)196 (25.0)
Multiracial/other68 (7.9)136 (13.6)
Education: less than a 4-year college degree347 (40.5)469 (59.7)<0.0001
Parity<0.0001
0496 (46.9)296 (37.7)
1362 (34.2)264 (33.6)
≥2193 (18.2)225 (28.7)
Elevated T2D risk121 (14.1)176 (22.4)<0.0001
Perinatal depression175 (20.4)232 (29.6)<0.0001
Attended postpartum visit846 (98.7)691 (88.0)<0.0001
Preterm delivery84 (9.8)98 (12.5)0.08
Cesarean delivery286 (33.4)261 (33.2)0.96
Use of GDM medication223 (26.0)234 (29.8)0.09
GEM trial arm0.08
Usual care455 (53.1)383 (48.8)
Intervention402 (46.9)402 (51.2)
  • Values are presented as frequencies (%).

  • Screening was defined as a 2-hour, 75-g oral glucose tolerance test within 4–12 weeks postpartum.

  • P values are results from Pearson’s χ2 tests comparing those screened versus unscreened.

  • T2D, type 2 diabetes.